Abstract:Aim: Elevated pulmonary artery pressure (ePAP) in response to high-altitude hypoxia is a critical physiopathological factor in the hypoxic adaptation that may lead to high-altitude pulmonary edema in the acute phase or high-altitude pulmonary hypertension in the long term. However, the sea-level predictors of risk factors for altitude-induced ePAP have not been examined. Thus, we aimed to identify the baseline systemic blood predictors of ePAP after acute high-altitude exposure. Materials and Methods: A total of 154 participants were transported to a high altitude 3,700 m from sea level within 2 h. Echocardiography examinations were performed to assess the mean pulmonary artery pressure (mPAP) and hemodynamics at both altitudes. All the individuals underwent blood tests to determine the concentrations of vascular regulatory factors. Univariate and adjusted logistic regression analyses were performed to identify the independent predictors of ePAP and factors related to ePAP. Results: The mPAP increased significantly from sea level to high altitude (19.79 ± 6.53–27.16 ± 7.16 mmHg, p < 0.05). Increased levels of endothelin (ET-1), Ang (1–7), Ang II, and bradykinin were found after high-altitude exposure, while the levels of nitric oxide (NO), prostaglandin E2 (PEG2), and serotonin decreased sharply (all p -values < 0.05). At high altitude, 52.6% of the subjects exhibited ePAP, and the mPAP was closely correlated with the baseline Ang II level ( r = 0.170, p = 0.036) and follow-up levels of NO ( r = −0.209, p = 0.009), Ang II ( r = 0.246, p = 0.002), and Ang (1–7) ( r = −0.222, p = 0.006) and the left atrial inner diameter (LAD, r = 0.270, p < 0.001). Both the baseline and follow-up NO and Ang II levels were significantly different between the ePAP and non-ePAP groups. Finally, we identified the baseline Ang II and NO concentrations as two independent predictors of ePAP ( p < 0.05). We also found that two vascular regulatory factors with inverse roles, namely, Ang (1–7) and Ang II, at high altitudes were independently associated with ePAP. Additionally, ET-1, NO, PEG2, and LAD were associated with ePAP. Conclusion: The baseline concentrations of Ang II and NO at sea level are two independent predictors of ePAP after acute high-altitude exposure. Furthermore, Ang (1-7) and Ang II combined with ET-1, NO, PEG2, and LAD at high altitudes may contribute to the development of ePAP.

The Plasma Level Changes of VEGF and Soluble VEGF Receptor‐1 Are Associated with High‐altitude Pulmonary Edema

Admission Plasma Visfatin Level Strongly Correlates with Hematoma Growth and Early Neurologic Deterioration in Patients with Acute Spontaneous Basal Ganglia Hemorrhage.

TNF-α and RPLP0 drive the apoptosis of endothelial cells and increase susceptibility to high-altitude pulmonary edema

Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness

Effect of Hypoxia on Expression of AQP4 and HIF-1αin Protein in Prefrontal Cortex of Rats

Expression of Aquaporin-1 and Aquaporin-5 in a Rat Model of High-Altitude Pulmonary Edema and the Effect of Hyperbaric Oxygen Exposure

Systemic Blood Predictors of Elevated Pulmonary Artery Pressure Assessed by Non-invasive Echocardiography After Acute Exposure to High Altitude: A Prospective Cohort Study

Hypoxia-Induced Inflammatory Chemokines in Subjects with a History of High-Altitude Pulmonary Edema

Acute changes in cardiac dimensions, function, and longitudinal mechanics in healthy individuals with and without high‐altitude induced pulmonary hypertension at 4559 m

Preliminary screening of biomarkers in HAPE based on quasi-targeted metabolomics

Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema.

Decoding the Immune Response and Its Biomarker B2M for High Altitude Pulmonary Edema in Rat: Implications for Diagnosis and Prognosis

Stress Failure Plays a Major Role in the Development of High-Altitude Pulmonary Oedema in Rats.

Role of vascular endothelial growth factor in the changes of permeability of blood-brain barrier and its relationship with cerebral edema in high altitude

New Insights of Aquaporin 5 in the Pathogenesis of High Altitude Pulmonary Edema

Physiopathology of High-Altitude Pulmonary Edema.

Prediction of Pulmonary Edema by Plasma Protein Levels in Patients with Sepsis.

Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.

Early hours in the development of high-altitude pulmonary edema: time course and mechanisms

Evaluation of the cell death markers for aberrated cell free DNA release in high altitude pulmonary edema

Risk factors underlying high-altitude pulmonary edema in the Ecuadorian Andes